SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-13-272547
Filing Date
2013-06-26
Accepted
2013-06-26 16:18:48
Documents
5
Effectiveness Date
2013-06-26

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d560032ds8.htm S-8 35441
2 EX-4.3 d560032dex43.htm EX-4.3 72304
3 EX-5.1 d560032dex51.htm EX-5.1 5065
4 EX-23.2 d560032dex232.htm EX-23.2 1579
5 GRAPHIC g560032ex5_1.jpg GRAPHIC 7364
  Complete submission text file 0001193125-13-272547.txt   125748
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-189608 | Film No.: 13934672
SIC: 2836 Biological Products, (No Diagnostic Substances)